SARA LEGLEITER: Open Payments
NPI 1811966302 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,655 in 87 payments from 24 companies in 2025. Trend: 2023 $3,774 · 2024 $3,566 · 2025 $2,655
Food & beverage: $1,610Speaker / faculty: $1,045
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 2 | $1,070 |
| Amgen Inc. | 15 | $276 |
| ABBVIE INC. | 13 | $209 |
| Corcept Therapeutics | 5 | $178 |
| Novo Nordisk Inc | 7 | $110 |
| Lilly USA, LLC | 6 | $98 |
| Astellas Pharma US Inc | 3 | $84 |
| PFIZER INC. | 5 | $83 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| Inspire Medical Systems, Inc. | 2 | $51 |
Products named: NEXPLANON, Korlym, EVENITY, VRAYLAR, Veozah, JARDIANCE, QULIPTA, INSPIRE.
Industry payments across NE — which companies pay providers there.
